0001477932-23-007984.txt : 20231030
0001477932-23-007984.hdr.sgml : 20231030
20231030215151
ACCESSION NUMBER: 0001477932-23-007984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20231030
DATE AS OF CHANGE: 20231030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moore Duncan
CENTRAL INDEX KEY: 0001888265
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41555
FILM NUMBER: 231362113
MAIL ADDRESS:
STREET 1: C/O ASP ISOTOPES INC., 433 PLAZA REAL
STREET 2: SUITE 275
CITY: BOCA RATON
STATE: FL
ZIP: 33432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASP Isotopes Inc.
CENTRAL INDEX KEY: 0001921865
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890]
IRS NUMBER: 872618235
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1101 PENNSYLVANIA AVENUE NW
STREET 2: SUITE 300
CITY: WASHINGTON
STATE: DC
ZIP: 20004
BUSINESS PHONE: 202-756-2245
MAIL ADDRESS:
STREET 1: 1101 PENNSYLVANIA AVENUE NW
STREET 2: SUITE 300
CITY: WASHINGTON
STATE: DC
ZIP: 20004
4
1
form4.xml
FORM 4
X0508
4
2023-08-10-05:00
false
0001921865
ASP Isotopes Inc.
ASPI
0001888265
Moore Duncan
C/O ASP ISOTOPES INC.
1101 PENNSYLVANIA AVENUE NW, SUITE 300
WASHINGTON
DC
20004
true
false
false
false
false
Common Stock
2023-08-10-05:00
4
A
false
200000
0.00
A
750000
D
Common Stock
2023-10-26-05:00
4
P
false
104167
0.96
A
854167
D
This special one-time equity award of 200,000 restricted shares was made in connection with the appointment of Mr. Moore to the Special Projects Committee of the board of Directors. Mr. Moore will vest in four equal installments every six months.
Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities).
/s/ Duncan Moore
2023-10-30-05:00